Background: Activation and sensitization of visceral afferent nerves by inflammatory
nerves, S1PR1, S1PR2, and S1PR3 are the major receptors expressed. Activation of these receptors has been reported to exhibit regulatory effects on sensory nerve functions. [4] [5] [6] [7] Studies in the somatosensory system have led to the hypothesis that S1P may contribute to inflammation-induced nociception. [8] [9] [10] The functional role of S1P in vagal nociceptive afferent nerves in the GI tract has yet to be determined.
Vagal afferent (along with efferent) nerves in the esophagus, in general, are considered to coordinate esophageal physiological functions such as peristalsis and swallowing. Recent studies have revealed that esophageal vagal afferents also have nociceptive subtypes that play an important role in sensing potential visceral tissue damage from noxious stimuli and mediating nocifensive reflex. 11 Our previous studies have demonstrated that the esophagus is richly innervated by two subtypes of vagal nociceptive C-fibers: one subtype derived from neural crest neurons situated in the jugular vagal ganglia and the other subtype placodal in origin that situated in the nodose ganglia. In addition, the esophagus is also innervated by low threshold mechanosensory A∂ fibers arising from the nodose ganglia. The two subtypes of C-fibers have a high threshold to mechanical distension, and their activation responses are not saturated in the noxious distension range. They are also responsive to noxious chemical stimulations (such as capsaicin and mustard oil). 12 Our recent studies further demonstrated that certain chemical stimulations (acid at lower pH and menthol) preferentially activate esophageal jugular Cfibers but not nodose C-fibers, suggesting a distinctive functional difference between these two vagal nociceptive C-fibers. 13, 14 A recent RNAseq analysis of vagal nodose and jugular C-fiber neurons revealed that as with the somatosensory system, vagal nociceptors express S1PR1, S1PR2, and S1PR3 receptor mRNA. Neither jugular nor nodose C-fiber neurons expressed appreciable amounts of S1PR4 or S1PR5 mRNA. 15 In the present study, we aimed to investigate the effects of S1P on vagal nociceptive C-fiber subtypes that innervating the esophagus.
| ME THODS

Male Hartley guinea pigs (150-200 g) were purchased from Hilltop
Laboratory Animals (Scottsdale, PA, USA). All experiments were approved by Johns Hopkins University Animal Care and Use Committee.
| DiLLabelingofesophagealvagalafferent neuronsandcellpicking
Single-cell RT-PCR study on mRNA expressions of S1P receptor subtypes (R1, R2, and R3) was performed according the methods in our previous study. 14 
| Single-cellRT-PCR
The tubes with esophageal-labeled and -unlabeled jugular/nodose single cell suspended in RNAse OUT were used to synthesize firststrand cDNA by using the SuperScript III First-Strand Synthesis System for RT-PCR (Cat#18080; Invitrogen, Carlsbad, CA, USA)
according to the manufacturer's recommendations. Briefly, cell
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• Sphingosine-1-phosphate (S1P) level increase during tissue inflammation, but its effect on afferent nerves in the gastrointestinal tract is unknown.
• S1P-evoked action potential discharges in esophageal jugular but not nodose C-fibers. The transcripts of S1P receptor subtypes (S1PR1 and R3) were highly expressed in esophageal-labeled vagal nodose and jugular neurons. The agonists of S1P receptor subtypes (S1PR1 and R3) each partially mimicked S1P-induced activation effects in jugular C-fibers.
• This helps to better understand the mechanism of visceral inflammatory nociception.
samples were defrosted and then oligo(dT) and random hexamer and extension at 72°C for 1 minute followed by a final extension at 72°C for 10 minutes. PCR products were then visualized in ethidum bromide-stained 1.5% agarose gels. The primers included (1) S1PR1:
forward (5′-3′) CCT GTT GGG TCA TCT CGC TT, reverse (3′-5′) TCT TGC GGA AGG TAA GCC TG, product size was 222 bp; (2) S1PR2:
forward (5′-3′) TGG TCT TGT ACG TCC GCA TC, reverse (3′-5′) GGG TGG CAA AGG CAA AGA AG, product size was 219 bp; (3) S1PR3:
forward (5′-3′) CTT GGC CAA TGA GAC ACT GC, reverse (3′-5′) TGA
CCT TGT ACA GCA CAC CG, product size was 248 bp.
| Extracellularsingle-unitrecordingexvivoin esophageal-vagal preparation
We performed extracellular single unit recordings from nodose or jugular neurons in ex vivo esophageal-vagal preparations with intact nerve endings in the esophagus by the methods as described in our previous studies. 12, 13 After animals were killed by CO 2 inhalation and exsanguination, the esophagus and trachea with intact bilateral extrinsic vagal innervation (including jugular and nodose ganglia) were dissected and pinned in a sylgard-lined perspex chamber. The two compartments were separately superfused with Krebs bicarbonate buffer (KBS, pH 7.4, 35°C, 4-6 mL/min). Polyethylene tubing was in- After recording the baseline spontaneous activity and mechanical excitability, S1P (10 μM) was perfused to the serosal surface of the esophagus for 30 minutes. The AP discharges (if activated)
induced by S1P were recorded continuously for 30 minutes and analyzed in 1 second bins (yielding the number of APs in each second, Hz). The esophageal distension-evoked responses were also detected before and after S1P perfusion. Esophageal distensionevoked AP discharges were compared in the absence and presence of S1P (before and by the end of 30 minutes perfusion of S1P).
Then, S1P was washed out with fresh KBS (pH = 7.4) for 60 minutes, and AITC-and/or capsaicin-evoked AP discharges were recorded (60 minutes washing with fresh KBS between AITC and capsaicin).
Similarly, the effects of S1P receptor agonists were recorded and compared in esophageal vagal afferent C-fiber subtypes.
| Chemicals
Most chemicals used in the experiments were purchased from Cayman (Ann Arbor, MI, USA), including S1P, S1PR1 agonist SEW2871, and S1PR3 agonist CYM5541. Capsaicin and AITC (allyl isothiocyanate) and capsaicin were purchased from Sigma-Aldrich.
The stock solution of capsaicin (10 mM) was prepared in ethanol and working solutions were prepared freshly by the day of use.
AITC was prepared freshly with KBS. All other chemicals (S1P and S1PR agonists) were prepared freshly with KBS within 1 hour before application.
| Dataanalysis
In the extracellular study, we only analyzed the data of either capsaicin-or AITC-responsive C-fibers, as these would confirm that the nerve terminals were exposed to chemical perfusion. The agonistevoked nerve response was quantified as the peak frequency (Hz) of the AP discharge at the bin size of 1 second within a 5-minute period, averaged from 6 recording periods for a total of 30 minutes.
Similarly, the total number of AP discharges were calculated and compared before and after perfusion with S1P. According to our previous study, the peak frequency was correlated well with the total number of AP discharges that evoked by both the mechanical distension and chemical perfusion in the esophagus; 12 therefore, we only presented the peak frequency of AP discharges to indicate the activation responses to esophageal distension, AITC, and capsaicin.
The peak frequency (Hz) and the total number of the AP discharges were presented as means ± SEM and compared by paired t test or one-way ANOVA. For all experiments, significance was defined as P < .05.
| RE SULTS
We evaluated the effect of S1P on jugular and nodose C-fibers in the guinea pig esophagus. The average conduction velocity of nodose C-fibers innervating the esophagus was 0.6 ± 0.05 m/s (n = 8), and that of jugular C-fibers was 0.72 ± 0.06 m/s (n = 17).
| S1PonjugularC-fibers
In 8 of 9 preparations, superfusion with S1P (10 μM) activated the esophageal jugular C-fibers under study ( Figure 1 ). The activation was a sporatic firing that continued over about 20-minute period.
By 30 minutes, the AP firing was back to baseline levels. We elected to quantify the response in two-way, firstly, as the peak number of APs in any given 1 seconds bin, and secondly, the total number of peak APs in any consecutive 5 minutes bin. As shown in Figure 2B , the peak of AP discharge in any one second bin was significantly increased from the baseline (1.50 ± 0.54 Hz vs 4.4 ± 0.9 Hz, P < .05, N = 8; Figure 1A and B). Similarly, when we totaled the peak number of APs in any consecutive 5-minute bin, S1P induced an approximate 3-fold increase compared to baseline (42 ± 19 vs 150 ± 42, P < .05; Figure 1C ). For comparison purpose, we also included the responses to two classical C-fiber stimulants, capsaicin (to activate TRPV1)
and AITC (to activate TRPA1). The peak frequencies of APs were robustly increased by perfusion of either AITC (from 2.75 ± 1.37 Hz to 8.13 ± 0.74 Hz, P < .05, n = 7) or capsaicin (from 1.38 ± 0.38 Hz to 8.13 ± 0.74 Hz, P < .05, n = 9; Figure 1D and E). These TRP channel agonists caused a peak frequency discharges about twice that of S1P.
The mechanical excitabilities of jugular C-fibers were compared before the S1P perfusion and then again after the SIP-induced AP discharge returned to baseline (~30 minutes after initiation of perfusion). There were no significance changes in esophageal distension-evoked APs by S1P treatment before vs after S1P at distension pressures of 10, 30, and 60 mm Hg, respectively (before vs after S1P: 4.25 ± 1.68 Hz, 6.75 ± 2.18 Hz, and 11 ± 3.2 Hz vs 5.75 ± 2.11 Hz, 7.75 ± 2.55 Hz, and 9.75 ± 2.68 Hz, P > .05, n = 8; Figure 2 ).
| S1PonnodoseC-fibers
In contrast to jugular C-fibers, the esophageal nodose C-fibers did not respond to S1P. S1P perfusion (10 μM, 30 minutes) did not evoke
APs in esophageal nodose C-fibers. The peak frequency (1.0 ± 0.19 vs 2.13 ± 0.55 Hz) and the total number (7.8 ± 3.8 vs 9.6 ± 3.4) of APs did not significantly change before and after S1P perfusion ( Figure 3A and B). Nodose C-fibers did, however, respond to capsaicin and AITC with peak discharge frequencies similar to jugular C-fibers ( Figure 3C and D) . Like jugular C-fibers, S1P did not change the mechanical excitability in nodose C-fibers (peak frequencies of APs before vs after S1P at distension pressures of 10, 30, and 60 mm Hg, respectively: 3.00 ± 0.6 Hz, 6.5 ± 0.95 Hz, and 10.38 ± 1.21 Hz vs 3.88 ± 1.06 Hz, 7.50 ± 2.13 Hz, and 9.38 ± 2.69 Hz, P > .05, n = 8
( Figure 3E ).
| S1Preceptorgeneexpression
We addressed the hypothesis that the esophageal jugular C-fibers selectively responded to S1P because they expressed S1P receptors, whereas the nodose neurons did not. SP1 receptors are likely to be expressed by numerous non-neuronal cell types in the nodose ganglia; therefore, we dissociated the ganglia and picked individual neurons for a single-cell RT-PCR analysis. Based on the transcriptome analysis of vagal sensory neurons, 15 we focused our attention on S1PR1, S1PR2, and S1PR3 receptors. As the vagal ganglia neurons innervate areas other than the esophagus, we collected only those neurons that projected their fibers to the esophagus. To this end, we injected DiI into the wall of the guinea pig esophagus to retrogradely label the neurons. We collected 27 labeled jugular and 27 labeled nodose ganglia neurons. The gene expression profile of the S1P receptors did not provide an explanation for why jugular but not nodose C-fibers responded to S1P with AP discharge. In both jugular and nodose neurons, S1PR1 and S1PR3 were the receptors expressed in the largest percentage of neurons. In esophageal-specific jugular neurons, 48% (13/27) expressed S1PR1 and 44% expressed S1PR3. Seven neurons expressed both S1PR2 and S1PR3. S1PR2 was relatively rarely expressed in 3 of 27 labeled neurons (11%; Figure 4A ). Likewise, in esophageal-specific nodose ganglia neurons, S1PR1 expression rate was 41% and S1PR3 was 73% (20/27). Nine neurons (33%) expressed both S1PR1 and S1PR3. S1PR2 was also relatively rarely expressed in 3 of 27 labeled neurons (11%; Figure 4B ).
| S1PreceptoragonistsonjugularC-fiber
We evaluated the effects of S1PR1 and S1PR3 agonists to mimic S1P in activating esophageal jugular C-fibers in 8 experiments.
The S1PR1 selective agonist SEW-2871 mimicked S1P in stimulating the C-fiber in 4 of 8 preparations. SEW-2871 perfusion (10 μM, 30 minutes) significantly increased the peak frequency of APs from 1.75 ± 1.11 Hz to 6.00 ± 1.47 Hz (P < .05, n = 4; Figure 5A ). Likewise, the S1PR3 selective agonist (CYM-5541) also stimulated the jugular C-fiber (although not as strongly as S1P) in 5 of 8 experiments. The peak frequency of APs increased from the baseline of 0.4 ± 0.25 Hz to 2.80 ± 0.37 Hz (P < .05, n = 5) after CYM-5541 perfusion (10 μM, 30 minutes; Figure 5B ). In 3 experiments, the jugular C-fiber responded to both SEW-2871 and CYM-554.
| D ISCUSS I ON
Sphingosine-1-phosphate is abundant in the GI tract, 3 where it has been found to modulate the mucosal immune response and also regulate smooth muscle function. 16, 17 Whether S1P displays activation and/or sensitization effects on the adjacent afferent nerves has not yet been studied. Our data demonstrated that S1P was able to evoke AP discharge in vagal jugular C-fibers at their nerve terminals in the esophagus but failed to activate esophageal nodose C-fibers.
The data provide circumstantial evidence that this effect in jugular C-fibers may depend on activation of S1P receptors, in particular S1PR1 and S1PR3 that are expressed by the esophageal-specific vagal afferent nerves. S1P did not appear to non-selectively sensitize esophageal vagal afferent C-fibers to other activating stimuli such as mechanical distension.
Our previous studies have revealed that two distinct vagal C-fiber subtypes terminate in the guinea pig esophagus. 12 One subtype is derived from neurons situated in the nodose ganglia and the other subtype is derived from neurons situated in the jugular ganglia. Although both subtypes can be activated by classical C-fiber stimulants such as TRPV1 and TRPA1 agonists, there are striking differences between the subtypes with respect to their responses to inflammatory autacoids. For example, jugular C-fibers in the esophagus do not respond to 5-HT and purinergic P2X receptor agonists, but nodose C-fibers are strongly activated by these autacoids. 18, 19 Here, we show the converse: S1P consistently leads to activation of jugular C-fibers but fails to activate nodose C-fibers. S1P may, therefore, be a useful tool in discriminating jugular C-fiber-evoked reflexes and sensations from those originating from nodose C-fibers.
The mechanism underlying the activation of S1P remains unresolved. We favor the hypothesis that the activation of jugular C-fibers is secondary to activation of specific receptors. In support of this, virtually every esophageal-specific jugular C-fiber neuron expressed an S1P receptor. The major receptor subtypes expressed were S1PR1 and S1PR3, with many neurons expressing both of these receptors. In our functional studies, about 50% of the jugular C-fibers were stimulated by a S1PR1 or S1PR3 selective agonist. These functional results are in keeping with our gene expression data. It should be kept in mind, however, that these studies were carried out with a single relatively large concentration of the agonist, so the receptors selectivity should be cautiously interpreted. In our preparation, we typically study one fiber per animal per day. This laborious preparation is not ideal for the quantitative assessment of concentrationresponse curves with various agonists and antagonists that would be required to ferret out with more confidence the specific receptor subtype mostly involved in the S1P response.
Vagal jugular nociceptors are similar to DRG neurons in that they have a neural crest lineage. Indeed, in the esophagus, functional studies have revealed similarities in the terminals arriving from jugular and DRG C-fibers, both being distinct from nodose C-fibers. 20 Therefore, it may not be surprising that our findings here in vagal jugular C-fiber are consistent with what has been observed in the somatosensory system. S1PR1, S1PR2, and S1PR3 have been identified in small-sized DRG neurons at the protein level, 8, 21 and functional studies support a role of S1PR1 and S1PR3 in mediating S1P-induced activation/sensitization effects on DRG neurons in vitro and pain behavior in vivo. [6] [7] [8] 21, 22 If the AP discharge in response to S1P in jugular C-fibers is a response to activation of S1PR1 and/or S1PR3 receptors, then it is unclear why nodose C-fibers did not also respond. The expression profile of S1PRs in nodose neurons was similar to that found with jugular neurons. It should be kept in mind, however, that our analysis was qualitative but not quantitative. It is possible that the S1PRs are expressed at a greater density in jugular vs nodose neurons.
Alternatively, the superfused S1P gained preferential access to jugular terminals over nodose C-fiber terminals. This seems unlikely as we have found that the efficacy of several C-fiber agonists delivered via serosal superfusion is similar between nodose and jugular C-fibers (including AITC and capsaicin in the present study). Finally, it is possible that S1P is activating the jugular terminals in a manner independently of S1P receptors. Extracellular S1P has been studied in the somatosensory system where its effect on DRG neurons is thought to be through S1P receptor 1 and 3 and sometimes receptor 2 subtypes. [21] [22] [23] [24] [25] Patch clamp studies of isolated DRG neurons, however, have demonstrated that internal applications of S1P enhanced AP discharges evoked by current ramp in rat small-diameter DRG neurons without changing their firing threshold. 5 The fact that stimulation by S1P was selective for jugular C-fibers would, however, argue against a direct action on activating ion channels that are present in both jugular and nodose C-fibers (ie, TRPV1, TRPA1, NaV1 et al.).
The finding that S1P activated but not sensitized esophageal jugular C-fiber is different than our previous study with bradykinin.
Bradykinin not only overtly activated the terminals but also induced mechanical hypersensitivity in esophageal jugular C-fibers by interaction with downstream TRPA1. 18 It should be kept in mind that we only evaluated the mechanical sensitivity after S1P-induced AP discharge stopped (~30 minutes); therefore, it remains possible that the mechanical excitability may have been increased early during the S1P exposure during the time of overt activation of the terminals.
Sphingosine-1-phosphate is often elevated in inflammatory conditions; therefore, it is possible that S1P contributes to the neuronal symptoms (eg, pain and dysphagia) of esophageal inflammatory diseases. Moreover, clinical applications of S1P receptor agonists are currently being used in the treatment of autoimmune disorders such as multiple sclerosis. 2 The present findings may raise the awareness and concern for potential GI side effects of such therapies.
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